Probiotics as a therapeutic strategy in obesity and overweight: a systematic review
- 24 February 2021
- journal article
- review article
- Published by Brill in Beneficial Microbes
- Vol. 12 (1), 5-16
- https://doi.org/10.3920/bm2020.0111
Abstract
Obesity and overweight are two of the most health challenges with an increasing prevalence in recent years, in which several complications have been identified to have a high impact in patients’ he...This publication has 79 references indexed in Scilit:
- The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trialEuropean Journal of Clinical Nutrition, 2014
- Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjectsLipids in Health and Disease, 2014
- The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trialClinical Nutrition, 2014
- Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trialBritish Journal of Nutrition, 2013
- Effect ofLactobacillus gasseriBNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical TrialKorean Journal of Family Medicine, 2013
- The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot studyEuropean Journal of Clinical Nutrition, 2012
- Microbial degradation of complex carbohydrates in the gutGut Microbes, 2012
- Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trialEuropean Journal of Clinical Nutrition, 2010
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996